Concepedia

Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

Mila Shakya, Rachel Colin-Jones, Katherine Theiss-Nyland, Merryn Voysey, Dikshya Pant, Nicola Smith, Xinxue Liu, Susan Tonks, Olga Mazur, Jenny Clarke,

New England Journal of Medicine · 2019 · 184 citations · 24 references

DOIFull text

Open access

Abstract

A single dose of TCV was immunogenic and effective in reducing <i>S.</i> Typhi bacteremia in children 9 months to 16 years of age. (Funded by the Bill and Melinda Gates Foundation; Current Controlled Trials number, ISRCTN43385161.).

References

24

Emergence of an Extensively Drug-Resistant <i>Salmonella enterica</i> Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins

Elizabeth J. Klemm, Sadia Shakoor, Andrew J. Page et al. · mBio · 2018 · 622 citations · Full text

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

Vittal Mogasale, Brian Maskery, R. Leon Ochiai et al. · The Lancet Global Health · 2014 · 573 citations · Full text

, , +12

The Efficacy of a<i>Salmonella typhi</i>Vi Conjugate Vaccine in Two-to-Five-Year-Old Children

Feng Lin, Vô Anh Hó, Ha Ba Khiem et al. · New England Journal of Medicine · 2001 · 470 citations · Full text

Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010

Geoffrey Buckle, Christa L. Fischer Walker, Robert E. Black · Journal of Global Health · 2012 · 440 citations · Full text

Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010.

Geoffrey Buckle, Christa L. Fischer Walker, Robert E. Black · PubMed · 2012 · 434 citations · Full text